Cross-Sector entity

Nasdaq

Company NDAQ
5.8

Across a 20-day span, the pace is roughly 7 stories per week. The busiest single day carried 4. Credentialing Technology is the most frequent co-covered peer, appearing in 4 of the 20 tracked stories. earnings accounts for 4 of the 20 tracked stories, while 10 other categories carry the remainder.

213 verified stories tracked

Last mentioned: 5d ago

Entity pulse

Recent coverage · Nasdaq

20 stories
5.8 avg impact
20% positive
20% negative

Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.

  • 20% positive
  • 60% neutral
  • 20% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Nasdaq

Across a 20-day span, the pace is roughly 7 stories per week. The busiest single day carried 4. Credentialing Technology is the most frequent co-covered peer, appearing in 4 of the 20 tracked stories. earnings accounts for 4 of the 20 tracked stories, while 10 other categories carry the remainder. Each carries 2.8 original sources on average. Negative sentiment appears in 20% of the tracked stories. This profile follows 20 Cross-Sector stories mentioning Nasdaq across the period from July 31, 2026 to August 19, 2026.

Stories tracked
20
Per week
7
Negative
20%
Sources per story
2.8

Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Nasdaq. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Zero-Emission Deadline

    New York target for a 100% zero-emission electricity sector.

  2. NY State Storage Target

    Deadline for New York to reach its 6 GW energy storage capacity goal.

  3. Potential Extension

    Aptorum may apply for a second 180-day period if compliance is not met but criteria are satisfied.

  4. Pilot Program

    Expected launch of a pilot program for select S&P 500 stocks on the new DLT infrastructure.

  5. Lockup Expiration Window

    An estimated $800 billion in insider and early-investor shares become eligible for sale, the dominant risk factor for SPCX.

  6. Compliance Deadline

    Final date for CXApp to meet the minimum bid price requirement or face delisting.

  7. Initial Compliance Deadline

    End of the first 180-day grace period to regain a $1.00 closing bid price.

  8. Q2 2026 Results and Business Update

    Datavault AI reports Q2 2026 results and reiterates a full-year 2026 revenue target of at least $200 million.

  9. Valion Bio announces technical assessment underway

    Valion Bio issued a press release stating the Ministry has begun technical assessment and issued a first round of questions on physicochemical characterization.

  10. Q2 2026 Earnings Report

    GlobalFoundries scheduled to release quarterly results, testing margin expansion and product mix shift.

  11. Friday Rebound

    Strong Amazon and Microsoft earnings spark a massive recovery; Kospi jumps nearly 20%, and US indices regain ground, though the week remains deeply negative.

  12. Nasdaq Correction

    Nasdaq falls over 10% from recent high, entering correction territory; Nvidia loses more than 5% and is overtaken by Apple as world's largest firm.

  13. Kospi Extends Losses

    Kospi drops a further 6%, deepening the rout; global AI-linked shares remain under heavy pressure.

  14. Kospi Tumbles

    South Korea's Kospi index falls 11.5%, led by SK Hynix and Samsung Electronics, on fears of memory chip commoditization and supply chain disruption.

  15. Completion of Parallel Asset Acquisition

    SNDL completed the transaction, obtaining indirect majority economic exposure to Parallel’s operations via Sunstream and TransactionCo.

  16. CXMT IPO and DUV Breakthrough

    CXMT lists on Shanghai stock exchange, surging 466% to 3.3tn yuan; reports emerge that China has developed its own DUV lithography tools.

  17. Public Announcement and Appeal Intent

    Empro Group publicly disclosed the delisting notice and stated it will request a hearing before a Nasdaq Hearings Panel to appeal.

  18. Ukraine MOH accepts Entolimod dossier

    Ukraine's Ministry of Health accepted Valion Bio's regulatory dossier for Entolimod for formal review under the Regulatory Equivalence Pathway.

  19. Director Sale

    Glenda Dorchak sells 4,000 shares at $58.22 under 10b5-1 plan, reducing direct holdings by 21%.

  20. Starship test launch

    SpaceX conducts its first Starship test flight since the IPO, a key event for investor confidence.

Stories mentioning Nasdaq 20

SaaS earnings Neutral 5

Datavault AI Targets $200M Revenue as SaaS Data Platform Scales

Datavault AI's business update frames its AI platform as an infrastructure play for data monetization and tokenization, now moving to commercial deployments. SaaS operators can track how vertical integration affects unit economics and go-to-market.

2 sources
Finance earnings Neutral 5

Datavault AI Reiterates $200M FY2026 Target in Q2 Update

Datavault AI's Q2 2026 update centered on its goal of at least $200 million in full-year revenue, as the Nasdaq-listed AI platform advances tokenization and data monetization. Investors get a strategic progress report rather than detailed quarterly metrics.

2 sources
Crypto market trends Neutral 5

RWA Tokenization Play Datavault AI Targets $200M 2026 Revenue

Datavault AI is moving real-world asset tokenization and data monetization toward commercial launch, with a $200 million full-year revenue target. Web3 participants should watch how AI-driven tokenization infrastructure integrates with exchange platforms.

2 sources
Healthcare regulation Neutral 5

Valion Bio: 1st National Registration Looms as Ukraine MOH Reviews Entolimod

Ukraine's Ministry of Health has moved Valion Bio's Entolimod dossier into technical assessment, a step toward what would be the drug's first national registration as an acute radiation syndrome countermeasure. The company says a decision could come as early as Q4 2026, though no procurement or stockpiling agreement exists.

2 sources

Source: hawaiitelegraph.com · finanznachrichten.de

Biotech acquisition Positive 6

Biotech Pivot: Aspire Snaps Up Auto Supplier with $200M Revenue for $30M Cash

Aspire Biopharma, a Nasdaq-listed biotech, has closed the acquisition of Dura Driver Control Systems, a non-pharma automotive supplier. The $30 million all-cash deal brings over $200 million in annual revenue and $22.3 million in EBITDA, signaling a dramatic diversification away from pure drug development and into industrial cash flow generation.

2 sources

Source: californiatelegraph.com · Dailyadvance

Startups market trends Neutral 5

MetaOptics Bets 100% on Metalens Ramp-Up, Shelves U.S. Dual Listing

In a bold pivot, deep-tech startup MetaOptics is abandoning its planned Nasdaq dual listing to refocus entirely on scaling metalens production and converting its U.S. customer pipeline. The move highlights a founder-led bet on organic growth over public-market funding.

2 sources
Crypto market trends Neutral 5

Galaxy Digital Adds Enterprise AI Expert to Board, Stock (GLXY) in Focus

Galaxy Digital appointed Steven Bandrowczak, a veteran with over 30 years in tech operations and AI advisory, to its Board of Directors. The move reinforces Galaxy's hybrid strategy of digital assets and data center infrastructure, potentially enhancing institutional credibility and M&A capabilities in the evolving crypto landscape.

2 sources

Source: prnewswire.com · thestarphoenix.com

Finance markets Neutral 5

$232,880 Insider Sale at GlobalFoundries: Should You Worry Before Earnings?

A GlobalFoundries director sold $232,880 in shares just ahead of the Q2 2026 earnings report, but the pre-planned 10b5-1 trade likely reflects routine diversification after a 41% stock surge. With the company’s margin expansion and upmarket shift in focus, the upcoming August 5 release is the real catalyst for investors to monitor.

2 sources

Source: Jonathan Ponciano; The Motley Fool · The Motley Fool

Startups market trends Negative 7

CXMT’s $365B IPO Reshapes AI Chip Landscape, Opening Doors for Startups

The record-smashing IPO of China’s CXMT and its homegrown DUV breakthrough are redrawing the AI hardware map. While posing threats to incumbents, these moves signal a fragmenting supply chain where agile startups can introduce novel memory architectures and alternative lithography approaches.

2 sources
Finance markets Negative 7

Kospi 11.5% Plunge Exposes AI Economy's Opacity After CXMT IPO

China's CXMT flew 466% on its $365bn IPO and unveiled indigenous DUV lithography, triggering a Kospi rout and Nasdaq correction. Strong Big Tech earnings stabilized markets, but the episode reveals acute concentration and geopolitical risk in the AI supply chain—demanding a re-rating of semiconductor exposure.

2 sources
SaaS product updates Positive 6

Waton Financial’s MoTA Slashes Advisory Costs—$6K Saved on $500K Portfolio

Waton Financial’s MoTA platform is bringing a SaaS-like multi-agent architecture to individual investors, aiming to replace the 1.2% annual advisory fee with a scalable, commission-free AI alternative. The public beta in Q3 2026 could upend the wealth-management SaaS stack by offering institutional-grade portfolio intelligence at a fraction of the cost.

2 sources
AI product launch Positive 6

4+ AI Agents Power MoTA: Waton Financial Democratises Hedge Fund Architecture

Waton Financial’s MoTA platform deploys an Agent Orchestration Engine coordinating at least four specialised AI agents—cross-market analysis, risk, portfolio construction, and insights—for individual investors. The public beta in Q3 2026 marks a rare example of multi-agent AI leaving the hedge fund lab and entering retail finance.

2 sources

Source: asiabulletin.com · portal.sina.com.hk